Number | Ticker | Country | Founded | IPO Year | Price | Revenue | Analyst Decision | Analyst Count |
---|---|---|---|---|---|---|---|---|
1 | United States | 2015 | N/A | $4.26 | $694,968,328.00 | Strong Buy | 5 | |
2 | Israel | 1996 | 2000 | $2.95 | $394,190,000.00 | Strong Buy | 4 | |
3 | United States | 2017 | 2023 | $3.38 | $0.00 | Strong Buy | 5 | |
4 | AKYAAkoya BioSciences Inc. | United States | 2015 | 2021 | $1.78 | $86,815,000.00 | Buy | 7 |
5 | United States | 1984 | 1992 | $1.46 | $44,266,305.00 | Strong Buy | 4 | |
6 | United States | 1995 | 2000 | $0.96 | $52,291,000.00 | Buy | 6 | |
7 | United States | 1969 | 2020 | $3.08 | $122,959,000.00 | Buy | 5 | |
8 | United States | 2012 | 2021 | $3.48 | $156,715,000.00 | Buy | 8 | |
9 | United States | 2010 | 2020 | $1.03 | $317,515,000.00 | Strong Buy | 4 | |
10 | United States | 2011 | 2016 | $0.92 | $7,703,000.00 | Strong Buy | 6 | |
11 | United States | N/A | N/A | $2.56 | $0.00 | Buy | 7 | |
12 | United States | N/A | N/A | $2.95 | $0.00 | Strong Buy | 9 | |
13 | United States | 2008 | 2021 | $1.65 | $0.00 | Buy | 7 | |
14 | United States | 2008 | 2015 | $0.69 | $126,617,000.00 | Buy | 6 | |
15 | United States | 2017 | 2021 | $1.92 | $0.00 | Strong Buy | 5 | |
16 | United States | 2021 | 2024 | $4.85 | $0.00 | Strong Buy | 7 | |
17 | United States | 2017 | N/A | $4.62 | $2,647,000.00 | Strong Buy | 4 | |
18 | United States | 2018 | 2021 | $1.20 | $16,146,000.00 | Strong Buy | 6 | |
19 | United States | 2019 | 2024 | $3.76 | $2,601,000.00 | Strong Buy | 6 | |
20 | United Kingdom | 1988 | 2021 | $3.05 | $240,382,000.00 | Strong Buy | 4 | |
21 | United States | 1989 | 2000 | $2.81 | $155,842,000.00 | Strong Buy | 6 | |
22 | United States | 1995 | N/A | $2.08 | $917,902,000.00 | Buy | 5 | |
23 | United States | 2021 | 2024 | $1.05 | $0.00 | Strong Buy | 4 | |
24 | United States | 1992 | 1993 | $2.90 | $581,905,000.00 | Strong Buy | 5 | |
25 | United States | 2017 | 2019 | $0.95 | $0.00 | Strong Buy | 4 | |
26 | United States | 2022 | N/A | $1.28 | $0.00 | Buy | 6 | |
27 | United States | 1961 | 2001 | $0.66 | $807,465,000.00 | Buy | 4 | |
28 | United States | 2006 | N/A | $1.41 | $0.00 | Strong Buy | 5 | |
29 | Israel | 2016 | N/A | $0.81 | $33,158,000.00 | Buy | 6 | |
30 | United States | 2016 | 2021 | $0.54 | $0.00 | Strong Buy | 4 | |
31 | United States | 2014 | 2016 | $3.94 | $0.00 | Strong Buy | 5 | |
32 | United States | 2005 | 2014 | $2.45 | $175,598,000.00 | Buy | 4 | |
33 | United States | 2015 | N/A | $1.46 | $0.00 | Buy | 5 | |
34 | United States | 2004 | N/A | $3.04 | $0.00 | Strong Buy | 7 | |
35 | United States | 2005 | 2020 | $0.80 | $65,562,000.00 | Strong Buy | 4 | |
36 | HIVEHIVE Digital Technologies Ltd. | Canada | 1987 | N/A | $2.20 | $120,999,000.00 | Strong Buy | 6 |
37 | United States | 2019 | 2021 | $0.70 | $2,684,000.00 | Strong Buy | 5 | |
38 | IRWDIronwood Pharmaceuticals Inc. | United States | 1998 | 2010 | $1.74 | $378,418,000.00 | Buy | 5 |
39 | United States | 2012 | 2019 | $1.33 | $0.00 | Strong Buy | 4 | |
40 | United Kingdom | 2015 | N/A | $2.52 | $1,000,000.00 | Strong Buy | 6 | |
41 | United States | 2008 | N/A | $4.09 | $14,963,000.00 | Buy | 6 | |
42 | Canada | 2017 | N/A | $1.13 | $182,959,000.00 | Strong Buy | 7 | |
43 | United States | 2019 | N/A | $3.66 | $7,980,000.00 | Buy | 5 | |
44 | United States | 2018 | 2021 | $1.52 | $0.00 | Buy | 4 | |
45 | United States | 2015 | 2020 | $2.79 | $33,668,000.00 | Buy | 5 | |
46 | United States | 2017 | 2021 | $3.71 | $0.00 | Buy | 5 | |
47 | United States | 2018 | 2021 | $1.40 | $0.00 | Strong Buy | 5 | |
48 | Singapore | 2012 | N/A | $4.57 | $2,797,000,000.00 | Buy | 9 | |
49 | United States | 2021 | N/A | $4.10 | $152,466,000.00 | Strong Buy | 10 | |
50 | United States | 2012 | N/A | $4.27 | $421,000.00 | Strong Buy | 4 |
The FinQuota filters have identified what they believe to be the "Best Under $5 Stocks to Buy on February 26, 2025" to buy now. However, please note that this information should not be considered as financial advice, as investing involves risks. We strongly recommend consulting with a qualified financial advisor before making any decisions regarding buying or selling stocks.